Description
Gefitinib is a medication primarily used in the treatment of non-small cell lung cancer (NSCLC) that harbors specific genetic mutations known as epidermal growth factor receptor (EGFR) mutations. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of specific proteins involved in cancer cell growth and spread. Gefitinib is specifically indicated for patients with locally advanced or metastatic NSCLC whose tumors have EGFR mutations. It is typically taken orally in tablet form.
Leon (verified owner) –
My order of product arrived much quicker than I expected. The fast delivery was very much appreciated.
Marylou (verified owner) –
The quality of these product is superb. They work just as well as the branded versions.
Rusty (verified owner) –
The packaging for my product was excellent. Everything was well-protected and arrived intact.
Amado (verified owner) –
These product are definitely worth the money. They’re affordable and work just as well as the more expensive options.